Research within Imec’s Human++ programme focuses on stem cell research. It is developing platforms for automated cell inspection methods in order to create pluripotent stem cells in clinical grade.
TEL will assist the research in the development of imagers and sensors for a platform for inspection of Induced Pluripotent Stem Cells (IPSCs).
A lens-free imager will be developed at imec to monitor IPSC colonies, and a silicon photonics biosensor to quantify biomolecules involved in stem cell proliferation.
TEL will send a researcher to imec for joint research in the life science field.
“By participating in imec’s “Human++” programme, TEL believes it will be possible to apply the technological strengths and expertise—both tangible and intangible—it has gained in the semiconductor production equipment business to the life science field,” said Yoshio Kinoshita from TEL.
“The environment of a semiconductor cleanroom combined with biolabs and a multidisciplinairy team of engineers, physicists, biomedical and chemical scientists, allows in-house cultivation of stem cell colonies, biochemistry development, and in-house testing with biological molecules and stem cell colonies,” said Kinoshita.
“Imec’s vision on future healthcare is one of high-quality and affordable diagnosis and treatment,” said Peter Peumans, director life sciences program at Imec.